Christopher C. Caillouet

Array ( [id] => 1193453 [patent_doc_number] => 06730789 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Composition for dyeing keratinous fibers containing 3 amino pyrazolo- 1,5-a pyridines, dyeing method, novel 3-amino pyrazolo-1,5-a pyridines' [patent_app_type] => B1 [patent_app_number] => 10/130535 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6678 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730789.pdf [firstpage_image] =>[orig_patent_app_number] => 10130535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865687 [patent_doc_number] => 20030191213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Novel flame retarding compounds' [patent_app_type] => new [patent_app_number] => 10/320155 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15527 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191213.pdf [firstpage_image] =>[orig_patent_app_number] => 10320155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678841 [patent_doc_number] => 20030228982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Substituted phenyl derivatives' [patent_app_type] => new [patent_app_number] => 10/318573 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29810 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228982.pdf [firstpage_image] =>[orig_patent_app_number] => 10318573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770628 [patent_doc_number] => 20030216568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments' [patent_app_type] => new [patent_app_number] => 10/318367 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61490 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216568.pdf [firstpage_image] =>[orig_patent_app_number] => 10318367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809572 [patent_doc_number] => 20030199511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/317914 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112262 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199511.pdf [firstpage_image] =>[orig_patent_app_number] => 10317914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856967 [patent_doc_number] => 07375227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Quinoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/501054 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27209 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375227.pdf [firstpage_image] =>[orig_patent_app_number] => 10501054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766137 [patent_doc_number] => 20030100537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate' [patent_app_type] => new [patent_app_number] => 10/303213 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5317 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100537.pdf [firstpage_image] =>[orig_patent_app_number] => 10303213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117271 [patent_doc_number] => 20050070572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies' [patent_app_type] => utility [patent_app_number] => 10/496159 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6255 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070572.pdf [firstpage_image] =>[orig_patent_app_number] => 10496159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163539 [patent_doc_number] => 20050085505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23' [patent_app_type] => utility [patent_app_number] => 10/496193 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5826 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085505.pdf [firstpage_image] =>[orig_patent_app_number] => 10496193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404770 [patent_doc_number] => 20040024011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL' [patent_app_type] => new [patent_app_number] => 10/302357 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6930 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024011.pdf [firstpage_image] =>[orig_patent_app_number] => 10302357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089702 [patent_doc_number] => 20050009815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => '4-Aminoquinoline compounds' [patent_app_type] => utility [patent_app_number] => 10/496614 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23505 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009815.pdf [firstpage_image] =>[orig_patent_app_number] => 10496614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7156176 [patent_doc_number] => 20050026915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => '2-Aminoquinoline compounds' [patent_app_type] => utility [patent_app_number] => 10/496615 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23956 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026915.pdf [firstpage_image] =>[orig_patent_app_number] => 10496615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668657 [patent_doc_number] => 07094899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Vitreous form of known bradykinin antagonist' [patent_app_type] => utility [patent_app_number] => 10/301614 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3369 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094899.pdf [firstpage_image] =>[orig_patent_app_number] => 10301614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1232015 [patent_doc_number] => 06693199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Method of making HIV protease inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/300638 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62342 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693199.pdf [firstpage_image] =>[orig_patent_app_number] => 10300638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248502 [patent_doc_number] => 06673811 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => '1H-pyrrolo 3,2-b pyridine-3-carboxylic acid amines as GABAA receptor ligands' [patent_app_type] => B1 [patent_app_number] => 10/299199 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21944 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673811.pdf [firstpage_image] =>[orig_patent_app_number] => 10299199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669654 [patent_doc_number] => 20030114638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Alkene borates and a process for covalently coupling organic compounds' [patent_app_type] => new [patent_app_number] => 10/298593 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9875 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114638.pdf [firstpage_image] =>[orig_patent_app_number] => 10298593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730836 [patent_doc_number] => 20030187026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/295833 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112173 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187026.pdf [firstpage_image] =>[orig_patent_app_number] => 10295833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740783 [patent_doc_number] => 20030158152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Protease inhibitors and their pharmaceutical uses' [patent_app_type] => new [patent_app_number] => 10/181817 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12202 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158152.pdf [firstpage_image] =>[orig_patent_app_number] => 10181817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7218280 [patent_doc_number] => 20050054853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Process for producing optically active oxoheptenoic acid ester' [patent_app_type] => utility [patent_app_number] => 10/495268 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4028 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054853.pdf [firstpage_image] =>[orig_patent_app_number] => 10495268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706863 [patent_doc_number] => 20030153597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Aryl aniline beta2 adrenergic receptor agonists' [patent_app_type] => new [patent_app_number] => 10/292211 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20501 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153597.pdf [firstpage_image] =>[orig_patent_app_number] => 10292211 [rel_patent_id] =>[rel_patent_doc_number] =>)